The University of Sheffield
Department of Cardiovascular Science

News

Results 31 to 45 of 70.

  1. Heart Attack Drug

    NICE gives the green light for new heart attack drug

    Ticagrelor, a new drug that could prevent one in five heart attack deaths, has been approved for use in patients by the National Institute for Health and Clinical Excellence (NICE).

    Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health
  2. Lauren Mallinson BHF Manager

    Researchers put heart into charity walk

    A team of 20 heart attack researchers will put their best feet forward when they take part in a sponsored walk along Sheffield’s river banks

    Categorised under: University of Sheffield, Cardiovascular Science, Research and Medicine-Dentistry-Health
  3. AlexBasran

    Sheffield City doctor gets research funding

    A doctor from The University of Sheffield has been awarded a Research Training Fellowship of £147,814 from Yorkshire charity Heart Research UK. Dr Alexander Basran, aged 32, will be carrying out research into the links between lung infection and heart attacks.

    Categorised under: University of Sheffield, Cardiovascular Science, Research and Medicine-Dentistry-Health
  4. Heart Attack Patient Supports Charity Walk

    A tram driver from Sheffield who suffered a heart attack and had to be fitted with a pacemaker is urging people to sign up to a new city walk and support the British Heart Foundation.

    Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health
  5. Heart

    Look North profile leading heart research

    BBC Look North recently visited Dr Julian Gunn (Senior Lecturer) at work in Sheffeld Teaching Hospitals NHS Foundation Trust to produce a piece on some exciting research being carried out into heart disease. The piece featured some eye-catching 3D images of the heart.

    Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health
  6. Blood Clot

    One in five heart attack deaths could be prevented with new drug

    Robert Storey, Professor of Clinical Cardiology at the University of Sheffield's Department of Cardiovascular Science, presented findings today that confirm one in five deaths in the year following a heart attack could be prevented if a new drug, ticagrelor, was used instead of the standard treatment, clopidogrel.

    Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health
  7. Heart

    Experts prove link between phosphate intake and heart disease

    Lowering phosphate intake in humans can reduce heart disease, according to research by experts at the University of Sheffield.

    This is the first time the connection between a high phosphate diet and atherosclerosis - the cause of heart disease - has been proven. The findings have been published in Arteriosclerosis, Thrombosis and Vascular Biology (2 June 2011).

    Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health
  8. BHF Visit to RHH

    Mum Jo is VIP Guest at Hospital

    A Mum living with heart failure was one of the guests at a laboratory open day in Sheffield giving people an insight into pioneering medical research at a city hospital.

    Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health
  9. HRH

    Centre for Biomedical Research Opening

    HRH The Duchess of Cornwall officially opened a new £2m Centre for Biomedical Research at the Northern General Hospital on 4th May and described it as an impressive facility which will play a vital part in future healthcare research.

    The Centre is a state of the art facility which is ensuring discoveries made in research are used to improve clinical care benefiting thousands of patients with bone and heart conditions.

    Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health
  10. Wear Red for Heart

    Wear Red for Heart - Fundraising Event

    Staff and students in the Department of Cardiovascular Science held a 'Wear Red' to work day on Monday 28th February in order to raise funds for the British Heart Foundation.

    Categorised under: University of Sheffield, Cardiovascular Science, Students, Research and Medicine-Dentistry-Health
  11. Cyclist

    Why cycling to work is one of the biggest causes of heart attacks

    As any city cyclist will know, riding your bike in heavy traffic can be, metaphorically speaking, a heartstopping experience.

    But now research has found that it is literally one of the biggest triggers of heart attacks.

    Categorised under: University of Sheffield, Cardiovascular Science, Research and Medicine-Dentistry-Health
  12. Zebrafish

    The Science of Zebrafish

    The zebrafish is amazing. It can heal its own heart. Scientists believe they can unlock the secrets of the zebrafish to repair our damaged heart muscle. This is the topic of a new British Heart Foundation appeal which has been launched this week.

    Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health
  13. WRVS’ £1m gift to Sheffield Teaching Hospitals

    Patients at Sheffield Teaching Hospitals will benefit from a generous £1million gift from WRVS, presented by volunteers and the Rt. Hon. David Blunkett MP at a ceremony on 7 January.

    Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health
  14. Heart

    Breakthrough in drug trial offers hope for heart attack patients

    New findings from a major drug trial have brought experts a step closer to developing a drug which could prevent thousands of British deaths from heart attacks.

    Categorised under: University of Sheffield, Cardiovascular Science, Research and Medicine-Dentistry-Health
  15. Commonly used blood pressure drugs 'increase cancer risk'

    Researchers found significantly increased rates of all cancers among patients taking the drugs.

    The class of drugs, called Angiotensin-receptor blockers (ARBs), are widely used to treat high blood pressure as well as heart failure and kidney damage caused by diabetes.

    Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health